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OBJECTIVES In patients with a pulmonary vein (PV) source for atrial fibrillation (AF), we sought the use
of intracardiac echocardiography (ICE) to evaluate PV anatomy, guide radiofrequency (RF)
ablation and monitor for acute stenosis during ablation.
BACKGROUND A focal source for AF may be found in the proximal component of the PVs and can be
effectively treated by ablative techniques. However, the procedure may be challenging due to
the complex anatomy of the left atrium and PVs, uncertain catheter positioning within the
PVs and difficulties in mapping atrial extrasystoles, which may be rare or repeatedly induce
AF and require cardioversion.
METHODS Sixty-four patients were referred for RF ablation of a focal source of AF, and 56 were
identified as having AF triggers in 1 PV. Using ICE guidance, RF lesions were applied
around the circumference of the vein near the os until there was electrical isolation.
RESULTS Lesions were placed in 82 veins (36 right superior PV, 33 left superior PV, 9 left inferior PV,
4 right inferior PV); 24  12 lesions per vein were necessary to create electrical isolation with
a fluoroscopic time of 11  4 min and a mean of 22% reduction in luminal area. After a
follow-up of 13  7 months, 66% of patients remained free of AF, and another 13%
responded better to medications.
CONCLUSIONS We describe an anatomic approach to PV electrical isolation in which ICE is used to define
the anatomy, guide RF ablation and monitor for acute PV changes. (J Am Coll Cardiol
2002;39:1964–72) © 2002 by the American College of Cardiology Foundation
For many patients with paroxysmal atrial fibrillation (PAF),
an atrial ectopic focus may serve as the initiating event (1,2).
These sources of focal activity are frequently located in a
sleeve of myocardial tissue that may extend up to 4 cm
outside the adventitia of a proximal pulmonary vein (PV)
(3,4). Locating and mapping these foci may be difficult
owing to the complex and variable left atrial/pulmonary
venous anatomy (5), difficulties manipulating the catheters
within the PVs, and mapping atrial extrasystoles, which may
be rare or repeatedly induce atrial fibrillation (AF) and
require cardioversion. For these reasons, electrical isolation
of the PV, rather than limited ablation of the discrete
arrhythmogenic focus, has become a favored ablation ap-
proach. Another concern is that symptomatic PV stenosis
has been reported after extensive radiofrequency (RF) le-
sions in the left atrium (LA) and PVs, and increased
pulmonary venous flow velocity has been demonstrated in
up to 42% of patients with RF lesions localized to the PVs
(6–8). Nevertheless, RF catheter ablation or isolation of
these foci can significantly reduce or eliminate PAF epi-
sodes or improve the effectiveness of suppressive antiar-
rhythmic therapy (1,2,8–11).
One imaging modality, intracardiac echocardiography
(ICE), continues to develop and has become an important
adjunct to fluoroscopy for both focal and linear RF ablations
(12–16). Some noted advantages of ICE include anatomic
evaluation, precise localization of the ablation catheter,
guidance of tissue contact and ablation, evaluation of tissue
immediately after ablation, and immediate identification of
complications such as clot formation or pericardial effusions
(17).
We hypothesized that ICE could facilitate focal AF
ablations by defining the PV anatomy, guiding radiofre-
quency ablation and monitoring anatomic changes during
ablation to prevent PV stenosis.
METHODS
Patient selection. All patients had a history of PAF and
were referred to the electrophysiology lab at the University
of Virginia for AF ablation of presumed focal origin. They
had either failed or refused one or more antiarrhythmic
medications for AF suppression. Patients were classified
into one of four categories based upon AF frequency: daily,
weekly, monthly or fewer than once a month. A 24-h
Holter monitoring or 30-day event recorder was not re-
quired but was obtained in 45% of patients. These demon-
strated either frequent premature atrial contractions (PACs)
or short periods of AF preceded by atrial tachycardia and/or
PACs.
Strategies to prevent thromboembolism. Before the elec-
trophysiology procedure, a transesophageal echocardiograph
(TEE) was performed to exclude left atrial thrombi. These
were performed with an ATL HDI 5000CV imaging
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system (Philips Medical Systems, N.A., Bothell, Washing-
ton). Benzocaine 20% was used for local anesthesia, and
intravenous midazolam was used for sedation. If a thrombus
was present, no electrophysiology (EP) procedure was at-
tempted.
During the EP procedure, 7,500 to 10,000 U of heparin
was administered immediately after the double transeptal
puncture. Activated clotting times (ACTs) were monitored
every 30 min with additional boluses of heparin adminis-
tered in order to maintain the ACT 300.
At the end of the procedure, intravenous protamine (30
to 40 mg) was given to facilitate sheath removal. Patients
were hospitalized overnight for observation and discharged
the next day. Each patient received three days of subcuta-
neous enoxaparin (1 mg/kg twice daily) during initiation of
warfarin therapy and was maintained on warfarin for at least
one month after the procedure.
Catheter placement. Each patient received conscious se-
dation using intravenous midazolam and fentanyl. Venous
access was obtained in the right and left femoral veins and
left subclavian vein. A Fischer Tangent V fluoroscopic
imaging system (Fischer Imaging Corp., Denver, Colorado)
with pulsed imaging at 7 frames/s was used throughout all
studies. Two soft-tipped, 60-cm sheaths with 120° and 55°
distal curves (EP Technologies, San Jose, California) were
introduced through the right and left femoral veins, respec-
tively, and advanced to the right atrium. A double transeptal
catheterization was then performed using a Brockenbrough
needle under ICE-guidance (as described in the following
text) with a 9F, 9 MHz catheter and ClearView imaging
system (Boston Scientific, San Jose, California) (10,18).
The 120° sheath was positioned in the right superior PV
(RSPV) and the 55° sheath in the left superior PV (LSPV).
Quadripolar mapping/ablation catheters (EP Technologies)
were positioned through the sheaths to record PV potentials
(PVP).
Additional mapping catheter placement included a 20-
pole deflectable Halo catheter (Cordis Webster) positioned
in the right atrium, a decapolar catheter (Daig,
Minnetonka, Minnesota) positioned in the coronary sinus
and a quadrapolar catheter (Cordis Webster, Baldwin Park,
California) positioned in the right ventricle.
Intracardiac echocardiography. A 9F 9 MHz ICE cath-
eter with the ClearView imaging system (Boston Scientific)
was used to aid in the transeptal puncture. Initially, the ICE
catheter was placed in a 55° curve sheath with the tip of the
catheter placed at the fossa ovalis. Under ICE guidance,
along with hemodynamic and fluoroscopic monitoring, a
transeptal puncture was performed with a Brockenbrough
needle through a 120° curve sheath. After successfully
crossing the septum, the ICE catheter and the Brocken-
brough needle with dilator were exchanged. With the ICE
catheter inserted in the 120° sheath, placed at the fossa
ovalis with imaging through the sheath, a second transeptal
puncture was performed with the 55° sheath.
The sheaths were placed in the superior PVs. By ex-
changing the ICE catheter through each sheath, the loca-
tion could be confirmed and local PV anatomy examined.
Variability in PV anatomy was defined as “early branching”
if secondary venous branches were noted within 5 mm of the
ostium, “common ostium” if superior and inferior veins
shared same ostium and “additional ostia” if more than four
noted.
Intracardiac echocardiography was used to guide circum-
ferential RF ablation of PV (see the following text) and to
monitor for PV stenosis. Before any RF application,
planimetry of the PV was performed and repeated imme-
diately after electrical isolation of the vein.
Mapping. Multipolar electrode catheters were placed in
each superior PV. Bipolar electrode signals were filtered at
40 to 500 MHz and displayed on a Bard Duo recording
system (Bard Electrophysiology, Lowell, Massachusetts).
During sinus rhythm, PVPs were identified by a sharp
deflection preceded by a low amplitude potential. Mapping
was performed during sinus rhythm looking for either
isolated PACs originating from a PV or PV PACs initiating
episodes of AF. If PACs were absent or rare, provocative
maneuvers using isoproterenol infusion (0.5 to 4.0 g/min),
intravenous adenosine (6 to 12 mg), programmed electrical
stimulation and high-rate atrial pacing were used. A target
vein was defined as having ectopy in which the PVP
preceded all other atrial electrograms and surface P waves
with a distal to proximal activation sequence on the multi-
polar catheter positioned in the PV (Fig. 1). If ectopy
originated from other sites in the LA or in the inferior veins,
the mapping catheters were repositioned and location de-
termined by activation sequence mapping. If patients devel-
oped AF that persisted for 10 min, external direct cardio-
version was used for conversion to sinus rhythm. After
cardioversion, early ectopy was sought.
RF ablation technique. Once the target vein was identi-
fied, the ICE catheter was advanced into the targeted PV
through the soft-tip sheath (Fig. 2). This provided direct
visualization of the position of the ablation catheter tip and
guided placement of the catheter tip during RF energy
Abbreviations and Acronyms
ACT  activated clotting times
AF  atrial fibrillation
EP  electrophysiology
ICE  intracardiac echocardiography
LA  left atrium
LSPV  left superior pulmonary vein
PAC  premature atrial contraction
PAF  paroxysmal atrial fibrillation
PV  pulmonary vein
PVP  pulmonary vein potential
RF  radiofrequency
RSPV  right superior pulmonary vein
TEE  transesophageal echocardiography
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delivery (Fig. 3). Circumferential ablation was performed
under ICE guidance to the proximal component of the vein,
near the os, which was free of branches and had a diameter
of 1.0 cm. Radiofrequency energy was delivered using
EPT-1000TC generator (EP Technologies) with target
temperatures of 50° to 60°C (operator’s discretion) and
power limited to 25 to 30 W. Each RF lesion placed lasted
20 to 30 s. If target temperature was not reached, the power
was kept constant; rather the ablation catheter was reposi-
tioned using ICE to obtain better tissue contact. The
pre-ablation pacing threshold of the PV at 5 mm distal to
the line of ablation was determined and repeated after
completion of RF ablation. Electrical isolation of PV was
identified by bidirectional conduction block, that is, loss of
PVP during sinus rhythm and inability to conduct out of the
vein towards the LA when pacing distal to the ablation line
at high outputs (20 mA) (Fig. 4). With an axial view from
the ICE, initially 12 lesions were applied (at 1 o’clock to 12
o’clock positions). If the PV was not electrically isolated,
additional lesions were applied to areas on the circumfer-
ential line with sharp potentials. If loss of PVP was noted
during the initial 12 lesions and there was loss in ability to
Figure 1. Ectopic focus originating from within a pulmonary vein. (A) A premature atrial contraction originating from the right superior pulmonary vein
(RSPV) is noted by the arrow. It precedes all other intracardiac recordings and surface P-wave. Additionally, within the vein there is distal to proximal
activation. (B) An ectopic beat from the same vein serves as a trigger for atrial fibrillation. D distal; DCS distal coronary sinus; HALO duodecapolar
catheter in right atrium; LSPV  left superior pulmonary vein; MCS  middle coronary sinus; P  proximal; PCS  proximal coronary sinus.
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conduct out of the vein to the LA, then no further lesions
were given.
Patients with a history of atrial flutter or right atrial
flutter observed during procedure and confirmed with en-
trainment mapping also received a tricuspid annulus/
inferior vena cava linear lesion(s) until bidirectional
conduction block across the isthmus was demonstrated.
Additionally, ectopy-initiating AF that was outside the
Figure 2. Intracardiac echocardiography (ICE) placed in left superior pulmonary vein (LSPV). An ablation catheter and ICE catheter are placed within
the LSPV to guide radiofrequency ablation. (A) Fluoroscopic image of intracardiac catheters: duodecapolar catheter in right atrium with ICE and ablation
catheter in LSPV. (B) Concomitant image from ICE visualizing the ablation catheter within the LSPV lumen.
Figure 3. Positioning of the ablation catheter in the pulmonary vein. Intracardiac echocardiography (ICE) catheter is placed in the left superior pulmonary
vein along with a 4-mm tip Blazer radiofrequency ablation catheter. The catheter can be seen within the lumen of the vein. The tip of the ablation catheter
casts an echogenic shadow and allows precise location and apposition along the vessel wall. (A to D) Demonstrating catheter movement to the 12, 3, 6
and 9 o’clock positions.
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PVs was mapped with activation sequence mapping and
the foci ablated.
Follow-up. All patients were seen initially in the electro-
physiology clinic or referring physicians clinic within six to
eight weeks after procedure or sooner if patients developed
symptoms. During each visit, an electrocardiogram was
obtained, and the patient was questioned as to the recur-
rence of symptoms. Further clinic follow-up was performed
on at least an annual basis. Additionally, all patients were
contacted by telephone and were questioned about recur-
rence of symptoms. If patients had symptoms of palpita-
tions, Holter monitoring or event recorders were performed.
If AF recurrence was identified, antiarrhythmic medication
was started and a repeat PV isolation procedure or enroll-
ment in a linear ablation research protocol was offered to the
patient.
Ablation success was defined as absence of symptomatic
AF episodes without antiarrhythmic medications. Partial
ablation success was defined as a reduction in AF frequency
by one category (daily, weekly, monthly, or less than
monthly) with or without a previously failed antiarrhythmic
medication.
Figure 4. Electrical isolation of pulmonary vein (PV). Pacing threshold from within the PV was determined before ablation. After the intracardiac
echocardiography (ICE)-guided circumferential lesions were created, pacing thresholds were again determined. Electrical isolation was defined by
dissociation of an ectopic focus from within the vein or loss of PV potentials with pacing threshold distal to the ablation line exceeding 20 mA. (A) An
ectopic focus is noted within the vein but does not conduct into the atria and is dissociated from the sinus rhythm. (B) Pacing from within the vein distal
to the ablation line at 20 mA fails to conduct to the atria. DCS  distal coronary sinus; HALO  duodecapolar catheter in right atrium; MAP D  distal
bipolar of mapping catheter; MAP P  proximal bipolar of mapping catheter; MCS  middle coronary sinus; PCS  proximal coronary sinus.
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Data analysis. Statistical analysis was performed using
Excel 5.0. Data is presented as mean with SD. Comparisons
of PV luminal area were performed using a two-tailed
Student t test. Significance was defined as p 0.05.
RESULTS
Patients. A total of 64 patients (42 males, 22 females) were
referred for “focal AF ablation” (Table 1). The mean age of
our study population was 52  12 years (range: 24 to 73),
and the average duration of PAF before the ablation
procedure was 5  5 years. A total of 81% of patients had
failed at least one class I or class III antiarrhythmic
medication.
TEE. Transesophageal echocardiography was performed
in 61/64 patients. The first patient in our series did not have
a TEE; and two additional patients were unable to undergo
TEE, because of significant esophageal pathology. A left
atrial appendage thrombus was identified in one patient;
therefore, no ablation procedure was performed.
Mapping and ICE-guided RF ablation. Only PVs that
were the site of origin for PACs underwent the electrical
isolation technique. Pulmonary vein PACs were absent in
7/63 patients; therefore, PV isolation was not performed in
these patients. In these patients, ectopy initiating AF were
either located in the right atrium (4), LA, (2) or no AF
trigger could be identified (1).
Intracardiac echocardiography was employed to define
regional PV anatomy. Variability in PV anatomy was seen in
20 patients (36%); 11 patients had a common os between
the upper/lower veins, seven patients had very early branch-
ing of a PV, and two patients had additional ostia.
Demonstration of PV PACs initiating an episode of AF
was observed in 40/56 patients. The other patients demon-
strated PV ectopy without AF initiation. Mapping was
performed with provocative maneuvers in 60 of 63 patients.
Isoproterenol infusion was given alone in 41%, and isopro-
terenol with additional provocative means that included
programmed electrical stimulation, rapid atrial pacing,
adenosine bolus and intentional induction of AF followed
with cardioversion and looking for early recurrence of AF
was used in 55% of the patients.
A total of 82 veins were targeted for isolation. A total of
84% of target veins were superior (36 RSPV; 33 LSPV). A
total of 61% of patients had one culprit PV, 32% of patients
had two PVs and 7% of patients had three PVs. Complete
electrical isolation with bidirectional conduction block was
achieved in 81 veins. An additional focal right or left atrial
source was noted in three patients and atrial flutter in 13
patients.
A mean of 24 12 lesions (10.8 8.8 min of RF energy)
were required to electrically isolate each PV. Four PVs were
electrically isolated during the initial lesion set of 12 lesions
(4, 6, 9, and 9 lesions). After RF ablations were delivered,
increased echogenicity could be seen (Fig. 5). Planimetry at
the ablation site revealed a mean acute reduction in cross-
sectional luminal area by 22  10% (p  0.001), which
corresponds to a 12% decrease in luminal diameter. In four
patients, circumferential ablation was terminated prema-
turely because of a 50% reduction in luminal area. How-
ever, electrical isolation was still achieved in three of the
four veins.
The mean procedural time was 243  75 min with a
mean fluoroscopy time of 11  4 min. The estimated
“fluoroscopic pedal time” is approximately 48.6 min.
Follow-up. After mean follow-up of 13  7 months,
37/56 patients (66%) remain free from symptomatic AF
after the initial procedure (34/56) or after a second proce-
dure (3/6). A total of seven patients returned for repeat
procedure due to AF recurrence (six focal and one linear
ablation protocol). Four of those patients had PV ectopy
from other veins not isolated on the original procedure.
Seven of the remaining 15 patients have a reduction in AF
frequency with or without previously failed antiarrhythmic
medication. No symptomatic PV stenosis has been ob-
served.
Complications. Two minor (pericarditis) and six major
complications occurred (one esophageal perforation, one
Mallory-Weis esophageal tear, one cardiac tamponade,
three cerebrovascular events). The esophageal perforation
was a complication of the TEE. The patient had no history
of esophageal pathology. The Mallory-Weiss tear was due
to severe nausea/vomiting after the procedure, possibly
related to pharmacologic agents used for sedation/analgesia.
All cerebrovascular events occurred during the first year of
performing focal AF ablations, and all occurred in patients
60 years old. Two patients had a prior history of transient
ischemic attacks. The first patient did not receive a pre-
procedure TEE; the other two patients had pre-procedure
TEEs that were negative for LA thrombi. All patients had
clinical presentation and post-event neurologic imaging that
Table 1. Baseline Patient Clinical Characteristics
Characteristics Number Percentage
Age 52  12
Male/Female 40/16
Cardiovascular disease
Hypertension 5 9%
Coronary artery disease 16 29%
Congestive heart failure 2 4%
Valvular heart disease 3 5%
Diabetes mellitus 4 7%
Other 2 4%
AF frequency
Daily 30 54%
Weekly 15 27%
Monthly 7 13%
Fewer than once a month 4 7%
History of cardioversion 19 34%
Antiarrhythmic drug failure
0 11 20%
1 18 32%
2 19 34%
3 8 14%
AF  atrial fibrillation.
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was consistent with embolism. Neurologic deficits have
persisted in one patient.
DISCUSSION
The PVs are well recognized as a source for focal triggers in
patients with paroxysmal AF and structurally normal hearts.
Methods of intracardiac mapping and ablation of these sites
continue to evolve. In this paper we have described a
method of identifying a “target vein” by PV PACs and
directly placing an ICE catheter across the intra-atrial
septum within the PV in order to evaluate the LA/PV
anatomy, guide RF delivery at the PV ostia and monitor for
acute tissue changes.
PV imaging. Significant variability in LA/PV anatomy is
known (5). In this series of patients, 36% had either more
than four PV ostia, common PV ostium or early branching.
We have found that fluoroscopy guidance alone is inade-
quate to determine the anatomy and for the subtle catheter
manipulations required to circumferentially ablate a PV,
particularly at the LA/PV junction.
The use of phased-array ICE placed within the right
Figure 5. Acute changes in pulmonary vein with radiofrequency ablation. A reduction in luminal area can be seen immediately after radiofrequency ablation.
There is increased echogenicity in the vessel wall along with thickening. (A) Pre-ablation of a right superior pulmonary vein. (B) Immediately after ablation.
RPA  right pulmonary artery; SVC  superior vena cava.
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atrium to identify and guide lesions at the PV os has been
described in an animal model (16). Although the LA and
PV junction can be seen well, exact catheter positioning
within the vein is difficult to determine with this imaging.
Intracardiac echocardiography placed within the PV and
containing a single rotating transducer provides a 360°
field of view and allows exact positioning of the ablation
catheter.
An additional potential advantage of this technique is
reduction in fluoroscopic time as most catheter manipula-
tion within the vein and monitoring for catheter stability
during RF delivery can be achieved with ICE-guidance
alone. However, comparisons with fluoroscopic times from
other studies are difficult as different systems are used with
different pulsed compression algorithms (5,10,11).
Comparison with other techniques. This ICE-guided
technique differs from initial ablation methods described in
five ways (11,19–23). First, only PVs from which PACs
originate are targeted for ablation. Second, initiation of AF
by these PACs was not required. Third, advanced mapping
in the LA or within the PV is not required. Fourth,
adjunctive imaging (ICE) is used to directly visualize
catheter positioning, tissue contact and lesion formation.
Fifth, bidirectional conduction block is used as the end
point. Presently, investigators are employing PV isolation
procedures that are map-guided using fluoroscopic or elec-
troanatomic imaging of ablation catheter positioning
(11,24). It is unknown whether the primarily anatomically
guided procedure described in the present paper is superior
to the map-guided techniques, but the success rates are
similar with the two techniques.
Complications. Pulmonary vein stenosis is a known, but
fortunately rare, complication following PV RF ablation.
Strategies to minimize this complication include: 1) reduc-
ing power; 2) setting lower target temperature; and 3)
limiting the number of RF ablations. In this series we
reduced the set power and temperature but did not limit the
number of ablations unless significant narrowing of the PV
was seen (four veins). We saw an acute reduction in luminal
area but have not had any symptomatic PV stenosis. The
acute effects probably represents edema or PV spasm. The
acute effects of RF lesions at the superior vena cava/right
atrial junction has been well described, and, in a series of
patients with inappropriate sinus tachycardia, a reduction in
the orifice diameter of 24% was seen (25,26). However, in
three patients who required a second procedure, no persis-
tent swelling was observed (25).
The experience of three cerebrovascular events in our
series of patients raises our concern that there may be
neurologic complications associated with catheter ablation
of “focal” AF. A review of thromboembolic complications
with all RF ablation in the left heart reveals a stroke risk of
2% to 2.8% (27). This risk may certainly be increased with
longer procedures and more extensive lesions in the LA.
Three modifications to our protocol were made since these
complications that occurred during the first year of perform-
ing this procedure. A higher saline flow through the 8.5F
soft-tipped sheaths was employed to reduce blood stasis
within the sheaths during RF ablation, ICE imaging and
catheter exchanges; patients were given aspirin on the
morning of the elective procedure for antiplatelet effect; and
patients 60 years are dissuaded from pursuing focal AF
ablation, particularly if they had a history of prior transient
ischemic attacks. All of the cerebrovascular events occurred
during the first 12 months of performing this procedure.
Although speculative, we believe that the cause was likely
related to technical problems during catheter manipulations
or changes. Since the institution of the three measures noted
above, no further cerebrovascular events have occurred at
our center over the last 20 months.
Study limitations. We restricted our population to patients
with paroxysmal AF. Therefore, the effects of this technique
on more persistent forms of AF are unknown. We demon-
strated an acute reduction in luminal area of 22% after RF
ablation, but we do not know the long-term effects or the
incidence of asymptomatic PV stenosis in these patients.
Additionally, success was defined on clinical grounds; there-
fore, we cannot exclude occurrence of asymptomatic PAF.
Conclusions. In summary, we conclude that, in a heterog-
enous population with paroxysmal AF, ICE-guided electri-
cal isolation of arrhythmogenic PVs can be an effective
treatment and a possible cure. The primary advantages of
this approach are the ability to obtain a detailed evaluation
of the PV anatomy, guide RF ablation and monitor for
acute changes in the vessel.
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